Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Aytu BioPharma, Inc. Q3 2026 Earnings Call Summary
Aytu BioPharma Inc (AYTU) Q3 2026 Earnings Call Highlights: Strong Exua Adoption Amid Revenue ...
Aytu (AYTU) Q3 2026 Earnings Transcript
Full Transcript: Aytu BioPharma Q3 2026 Earnings Call
Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call Transcript
Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
Aytu BioPharma Q3 EPS $(0.53) Misses $(0.51) Estimate, Sales $12.411M Beat $12.053M Estimate
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
Favourable Signals For Aytu BioPharma: Numerous Insiders Acquired Stock
Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Shift From Loss To Profit
Full Transcript: Aytu BioPharma Q2 2026 Earnings Call
Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ...
Aytu BioPharma, Inc. Q2 2026 Earnings Call Summary
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Q2 Earnings Report: What Investors Need to Know
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.